Researchers discovered a molecule that may be a potential therapy for patients recovering from a stroke. The molecule, known as growth and differentiation factor 10 (GDF10), is activated early after stroke, according to researchers from the department of neurology at the University of California, Los Angeles.

As part of its annual Medical Innovation Summit, the Cleveland Clinic released its top 10 medical innovations for 2016. The list of the technologies that will have the biggest impact in healthcare included neurovascular stent retrievers, which are used after patients suffer an ischemic stroke.

Quest Medical voluntarily recalled certain lots of its Myocardial Protection System (MPS) delivery sets on Oct. 28 after finding the products had a possible seal failure that could lead to blood loss in patients.

Major medical societies released updated guidelines on Oct. 21 regarding multivessel PCI and thrombus aspiration in patients with STEMI undergoing primary PCI.

Patients with coronary artery disease undergoing elective surgery for colorectal cancer had a long delay in the operation after receiving a stent, according to a Veterans Affairs analysis.

A long-term follow-up of patients who underwent cardiac surgery in Sweden found there was no association between red blood cell storage times and estimated mortality at 30 days, two years and 10 years.

The FDA approved the Sapien XT transcatheter heart valve on Oct. 15 for aortic valve-in-valve procedures.

Patients at high risk for bleeding who underwent PCI had better outcomes if they received a polymer-free umirolimus-coated stent compared with a bare-metal stent, according to a randomized, double blind trial.